Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 482.0 | 71 | |
RA2159 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 667.0 | 85 | |
RA2159 | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 654.0 | 75 | ||||
N2645 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 545.0 | 59 | |
N2645 | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 586.5 | 44 | ||||
RA2708 | Tofacitinib | 0.3 | uM | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 696.0 | 68 | |
RA2708 | IL-1 alpha | 100 | ng/mL | 4 | GM-CSF | 690.0 | 76 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 764.5 | 72 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 636.5 | 46 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 592.5 | 62 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 738.0 | 68 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 615.0 | 73 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 630.5 | 64 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 704.0 | 65 | |
RA2159 | TNF-a | 100 | ng/mL | 4 | GM-CSF | 649.5 | 76 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 735.0 | 49 | |
N2645 | TNF-a | 100 | ng/mL | 4 | GM-CSF | 633.0 | 48 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 4 | GM-CSF | 695.0 | 47 | |
RA2708 | TNF-a | 100 | ng/mL | 4 | GM-CSF | 671.0 | 39 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GM-CSF | 557.0 | 75 | ||||
RA2159 | IKK16 | 2.0 | uM | 4 | GM-CSF | 516.0 | 73 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GM-CSF | 486.5 | 54 | ||||
N2645 | IKK16 | 2.0 | uM | 4 | GM-CSF | 476.5 | 62 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 4 | GM-CSF | 463.5 | 74 | ||||
RA2708 | IKK16 | 2.0 | uM | 4 | GM-CSF | 550.0 | 63 |